secwatch.observer — SEC 8-K summary
======================================

Issuer:     BECTON DICKINSON & CO (BDX)
CIK:        0000010795
Form:       8-K
Filed at:   2023-02-02T23:59:59+00:00
Accession:  0000010795-23-000026
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BD reports Q1 FY2023 revenue $4.6B (-2.8% as reported); adj. EPS $2.98; raises guidance
--------------------------------------------------------------------------------

- Revenue of $4,586M decreased 2.8% as reported, increased 1.7% currency-neutral versus Q1 FY2022.
- Base business (ex-COVID diagnostics) revenue grew 0.4% as reported, 5.2% currency-neutral.
- GAAP diluted EPS from continuing operations $1.70; adjusted diluted EPS $2.98, down 6.0% YoY.
- Company raises full-year fiscal 2023 revenue and adjusted EPS guidance.
- Results exclude spun-off Diabetes Care business (Embecta) accounted as discontinued operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/10795/000001079523000026/0000010795-23-000026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/10795/000001079523000026/bdx-20230202.htm
  HTML page:      https://secwatch.observer/filing/0000010795-23-000026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer